Walter Ling

22.5k total citations · 7 hit papers
251 papers, 16.2k citations indexed

About

Walter Ling is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Walter Ling has authored 251 papers receiving a total of 16.2k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Public Health, Environmental and Occupational Health, 116 papers in Epidemiology and 69 papers in Cellular and Molecular Neuroscience. Recurrent topics in Walter Ling's work include Opioid Use Disorder Treatment (126 papers), Substance Abuse Treatment and Outcomes (105 papers) and Neurotransmitter Receptor Influence on Behavior (64 papers). Walter Ling is often cited by papers focused on Opioid Use Disorder Treatment (126 papers), Substance Abuse Treatment and Outcomes (105 papers) and Neurotransmitter Receptor Influence on Behavior (64 papers). Walter Ling collaborates with scholars based in United States, Australia and China. Walter Ling's co-authors include Richard A. Rawson, Steven Shoptaw, Donald R. Wesson, Sara L. Simon, Maureen Hillhouse, Peggy Compton, V. Charles Charuvastra, Michael McCann, Alice Huber and Catherine P. Domier and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Walter Ling

245 papers receiving 15.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DSM-5 Criteria for Substance Use Disorders: Recommendations and Rationale

2013 958 citations Walter Ling et al. profile →
Validation of the alcohol, smoking and substance involvement screening test (ASSIST)

2008 828 citations Walter Ling, Sara L. Simon et al. profile →
The Clinical Opiate Withdrawal Scale (COWS)

2003 718 citations Donald R. Wesson, Walter Ling Journal of Psychoactive Drugs profile →
Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine

2004 557 citations Paul M. Thompson, Kiralee M. Hayashi et al. profile →
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

2011 400 citations Walter Ling et al. profile →
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi‐site trial

2013 347 citations Walter Ling et al. profile →
Bupropion and Naltrexone in Methamphetamine Use Disorder

2021 147 citations Walter Ling, Steven Shoptaw et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Walter Ling United States	67	6.9k	6.7k	4.0k	2.9k	2.1k	251	16.2k
George E. Bigelow United States	67	5.4k 0.8×	5.5k 0.8×	3.5k 0.9×	3.0k 1.0×	1.6k 0.8×	314	14.8k
Maxine L. Stitzer United States	66	5.8k 0.8×	5.3k 0.8×	2.6k 0.7×	2.2k 0.7×	1.7k 0.8×	334	14.5k
Roger D. Weiss United States	72	6.7k 1.0×	3.9k 0.6×	2.3k 0.6×	2.1k 0.7×	1.6k 0.8×	351	17.3k
Wilson M. Compton United States	71	9.2k 1.3×	6.7k 1.0×	1.9k 0.5×	5.3k 1.8×	3.4k 1.6×	250	23.9k
Thomas R. Kosten United States	77	5.1k 0.7×	3.7k 0.5×	7.3k 1.8×	3.9k 1.3×	1.3k 0.6×	567	22.9k
Edward V. Nunes United States	66	5.6k 0.8×	4.0k 0.6×	2.5k 0.6×	3.0k 1.0×	1.7k 0.8×	378	13.8k
Kenzie L. Preston United States	59	2.9k 0.4×	3.1k 0.5×	3.8k 1.0×	2.3k 0.8×	849 0.4×	263	11.5k
Shane Darke Australia	71	9.6k 1.4×	7.6k 1.1×	1.6k 0.4×	2.5k 0.9×	1.8k 0.9×	304	17.7k
Mary Jeanne Kreek United States	68	3.0k 0.4×	2.6k 0.4×	10.3k 2.6×	2.4k 0.8×	1.7k 0.8×	443	20.3k
Michael Gossop United Kingdom	65	8.8k 1.3×	6.0k 0.9×	1.3k 0.3×	1.9k 0.7×	1.7k 0.8×	351	15.0k

Countries citing papers authored by Walter Ling

Since Specialization

Citations

This map shows the geographic impact of Walter Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Ling more than expected).

Fields of papers citing papers by Walter Ling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Ling. The network helps show where Walter Ling may publish in the future.

Co-authorship network of co-authors of Walter Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Walter Ling. A scholar is included among the top collaborators of Walter Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter Ling. Walter Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yang & Walter Ling. (2024). The Impact of New Quality Productive Forces on Carbon Emissions in Manufacturing Enterprises. Frontiers in Business Economics and Management. 16(3). 253–264. 1 indexed citations

Boyett, Brent, Vijay R. Nadipelli, Caitlyn T. Solem, et al.. (2022). Continued Posttrial Benefits of Buprenorphine Extended Release: RECOVER Study Findings. Journal of Addiction Medicine. 17(2). 182–189. 7 indexed citations

Ling, Walter, David Farabee, Vijay R. Nadipelli, & Brian Perrochet. (2020). <p>An Updated Version of the Treatment Effectiveness Assessment (TEA) [Letter]</p>. PubMed. Volume 11. 21–22. 6 indexed citations

Ling, Walter, Vijay R. Nadipelli, Arnie Aldridge, et al.. (2020). Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment: 12-Month Longitudinal Outcomes From RECOVER, an Observational Study. Journal of Addiction Medicine. 14(5). e233–e240. 39 indexed citations

Ling, Walter, Vijay R. Nadipelli, Caitlyn T. Solem, et al.. (2019). <p>Measuring recovery in opioid use disorder: clinical utility and psychometric properties of the Treatment Effectiveness Assessment</p>. PubMed. Volume 10. 13–21. 15 indexed citations

Ling, Walter, et al.. (2014). Treating Methamphetamine Abuse Disorder: As Prevalence of Methamphetamine Abuse Mushrooms, Practitioners Face the Challenge of Treating the Disorder, Its Withdrawal Symptoms, and Stimulant-Induced Psychosis. Current psychiatry. 13(9). 37.

Lü, Lin, Yanli Liu, Jie Shi, et al.. (2009). Traditional Medicine in the Treatment of Drug Addiction. The American Journal of Drug and Alcohol Abuse. 35(1). 1–11. 84 indexed citations

Berman, Steven M., Bradley Voytek, M. Mandelkern, et al.. (2007). Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse. Molecular Psychiatry. 13(9). 897–908. 61 indexed citations

Doran, Christopher M., et al.. (2005). Buprenorphine induction and stabilisation in the treatment of opiate dependence. Queensland's institutional digital repository (The University of Queensland). 7(1). 7–18. 19 indexed citations

10.

Newton, Thomas F., et al.. (2005). Apathy predicts hedonic but not craving response to cocaine. Pharmacology Biochemistry and Behavior. 82(1). 236–240. 5 indexed citations

11.

London, Edythe D., Steven M. Berman, Bradley Voytek, et al.. (2005). Cerebral Metabolic Dysfunction and Impaired Vigilance in Recently Abstinent Methamphetamine Abusers. Biological Psychiatry. 58(10). 770–778. 113 indexed citations

12.

Ling, Walter, Jerry Cunningham‐Rathner, & Richard A. Rawson. (2004). Diffusion of Substance Abuse Treatment: Will Buprenorphine be a Success?. Journal of Psychoactive Drugs. 36(sup2). 115–117. 5 indexed citations

13.

Rawson, Richard A., Michael McCann, Steven Shoptaw, et al.. (2001). Naltrexone for opioid dependence: evaluation of a manualized psychosocial protocol to enhance treatment response. Drug and Alcohol Review. 20(1). 67–78. 16 indexed citations

14.

Domier, Catherine P., Sara L. Simon, Richard A. Rawson, Alice Huber, & Walter Ling. (2000). A Comparison of Injecting and Noninjecting Methamphetamine Users. Journal of Psychoactive Drugs. 32(2). 229–232. 48 indexed citations

15.

Compton, Peggy, et al.. (2000). Pain Responses in Methadone-Maintained Opioid Abusers. Journal of Pain and Symptom Management. 20(4). 237–245. 135 indexed citations

16.

Bartzokis, George, Mace Beckson, Darwood B. Hance, et al.. (1999). Magnetic resonance imaging evidence of “silent” cerebrovascular toxicity in cocaine dependence. Biological Psychiatry. 45(9). 1203–1211. 54 indexed citations

17.

Shoptaw, Steven, Dominick L. Frosch, Richard A. Rawson, & Walter Ling. (1997). Cocaine Abuse Counseling as HIV Prevention. AIDS Education and Prevention. 9(6). 511–520. 30 indexed citations

18.

Stitzer, Maxine L., Sharon Walsh, Eric C. Strain, et al.. (1995). Clinical pharmacology of buprenorphine. 79–83. 8 indexed citations

19.

Wesson, Donald R., Walter Ling, & David E. Smith. (1993). Prescription of opioids for treatment of pain in patients with addictive disease. Journal of Pain and Symptom Management. 8(5). 289–296. 35 indexed citations

20.

Ling, Walter. (1978). Naltrexone: the clinical investigator's dilemma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 308–14. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact